Cited by 32Monoclonal and Polyclonal Antibodies Researchvaccines and immunoinformatics approachesComputational Drug Discovery Methods

AB-Gen: Antibody Library Design with Generative Pre-Trained Transformer and Deep Reinforcement Learning

Open access
Xu, Xiaopeng, Xu, Tiantian, Zhou, Juexiao, Liao, Xingyu, Zhang, Ruochi, Wang, Yu, Zhang, Lu, Gao, Xin·2023·Genomics, Proteomics & Bioinformatics

Published version of a preprint

Abstract

Antibody leads must fulfill multiple desirable properties to be clinical candidates. Primarily due to the low throughput in the experimental procedure, the need for such multi-property optimization causes the bottleneck in preclinical antibody discovery and development, because addressing one issue usually causes another. We developed a reinforcement learning (RL) method, named AB-Gen, for antibody library design using a generative pre-trained transformer (GPT) as the policy network of the RL agent. We showed that this model can learn the antibody space of heavy chain complementarity determining region 3 (CDRH3) and generate sequences with similar property distributions. Besides, when using human epidermal growth factor receptor-2 (HER2) as the target, the agent model of AB-Gen was able to generate novel CDRH3 sequences that fulfill multi-property constraints. Totally, 509 generated sequences were able to pass all property filters, and three highly conserved residues were identified. The importance of these residues was further demonstrated by molecular dynamics simulations, consolidating that the agent model was capable of grasping important information in this complex optimization task. Overall, the AB-Gen method is able to design novel antibody sequences with an improved success rate than the traditional propose-then-filter approach. It has the potential to be used in practical antibody design, thus empowering the antibody discovery and development process. The source code of AB-Gen is freely available at Zenodo (https://doi.org/10.5281/zenodo.7657016) and BioCode (https://ngdc.cncb.ac.cn/biocode/tools/BT007341).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.gpb.2023.03.004

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Xu, X., Xu, T., Zhou, J., Liao, X., Zhang, R., Wang, Y., Zhang, L., & Gao, X.
Affiliations
  • King Abdullah University of Science and Technology (SA)
  • Chinese Academy of Sciences (CN)
  • Syneron Technology , Guangzhou, 510000 , China
Corresponding author
Gao, Xin
Venue
Genomics, Proteomics & Bioinformatics
Published
2023-06-24
Volume
21
Issue
5
Pages
1043-1053
ISSN
  • 1672-0229 (ISSN-L)
  • 2210-3244
OpenAlex
W4381848602
Cited by
32
References
7
Citations by year
2026: 14 · 2025: 10 · 2024: 6 · 2023: 2
FWCI
5.46
Type
journal article
Language
en
Open access
Locations
  • Genomics Proteomics & Bioinformatics (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • King Abdullah University of Science and Technology Repository (King Abdullah University of Science and Technology) (submittedVersion, cc-by-nc-nd)
Funders
  • King Abdullah University of Science and Technology (FCC/1/1976-44-01, FCC/1/1976-45-01, REI/1/5234-01-01, URF/1/4352-01-01)
  • National Natural Science Foundation of China (22273107)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
Keywords
generative pre-trained transformer, deep reinforcement learning, multi-property optimization, HER2, antibody discovery, molecular dynamics, conserved residues
MeSH terms
Antibodies, Humans, Software, Gene Library, Molecular Dynamics Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review